Schuessler Tissue Salts Comb 5 Nerve Tonic Tablet, Chewable
FDA Label NDC 84999-025

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Martin & Pleasance Pty Ltd for the product Schuessler Tissue Salts Comb 5 Nerve Tonic (NDC 84999-025). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients                                                                                purpose, uses, warnings, directions, other information, inactive ingredients, product label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Uses

Temporarily relieves symptoms associated with

  • Stress
  • Mild anxiety
  • Mild neuralgic pain
  • General debility

Warnings

Ask a doctor before use if you have:

  • Symptoms persist for more than 24 hours or worsen 
  • New symptoms occur 
  • Redness or swelling is present
  • If pregnant or breastfeeding, ask a health professional before use.
    Keep out of reach of children.

Directions

  • Use as directed 
  • Take 30 minutes away from food.
  • Adults

    • Acute dose: Chew 1 tablet every 30 minutes until symptoms subside, up to 6 times per day. 
    • Maintenance dose: Chew 1 tablet, 4 times daily. 
    • Children 6 years and older:  

      • Acute dose: Crush ½ tablet, dissolve in water, and take every 30 minutes until symptoms subside, up to 6 times per day.
      • Maintenance dose: Crush ½ tablet, dissolve in water, 4 times per day.

Other Information

Store below 86°F

Inactive Ingredients

Calcium hydrogen phosphate, Lactose, Magnesium stearate.

Product Label

Image Description (Outer 25)

Image Description (Outer 25)

Image Description (Inner 25)

Image Description (Inner 25)

* Please review the disclaimer below.